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Introduction 
Although the pharmacology and clinical uses of procaine 
amide and quinidine are well known, there is r eally no con-
vincing work in the literature on the inotropic effects of 
these drugs . There are numerous statements attesting to the 
alleged facts that quinidine depresses contractility (5,14 , 
27,30,33), and that procai ne amide has no effect on c ontrac -
tility (14,22,27 , 33) . some of the early quoted literature 
(3,6) on quinidine attempt to draw conclusions from experiments 
done with a Marey tambour system . However, these conc lusions 
are probably not valid , since such a system measures changes 
in heart volume, and not contractility . Later work on iso -
lated frog hearts (5) reports that quinidine concentrations 
of l X l o- 6 increase contractile force, while higher concentra-
tions bave the opposite effect . ~ore recent work on isolated 
rabbit atria (34) states that quinidine has a negative ino -
tropic effect only at concentrations higher than l X lo- 5 . 
Observations on isolated tissues are based on non- physiologic 
conditions and may not apply to intact animals . 
one of the leading pharmacology textbooks (14) infers 
that quinid i ne depresses contrac tility from a report (30) 
which states that the drug reduces stroke volume , and work 
per beat in normal humans . However , re cent work with heart 
levers (10) and strain guage arches (9) shows that there is 
no direct or indirect relationship between contractile force 
and stroke volume under any circumstances, or between contrac tile 
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force and stroke work in conditions where the heart rate is 
increased and the peripheral resistance is simultaneously 
decreased (10). Since it is known that such conditions exist 
in unanesthetized humans given quinidine (13,14), and indeed 
in the study quoted above (30), the conclusions drawn there-
from are not valid. 
Ferrer 1 et al•, ( 13) report that the only change in circu-
~' 
lation produced by quinidine in normal human subjects is a 
fall in blood pressure due to decreased peripheral resistance, 
with no change in cardiac output. very recent work on dogs 
(15) supports the contention that quinidine's hypotensive 
effect is caused by a reduction in peripheral resistance. In 
this same study, the contractile force was measured directly 
( ' 
yff the myocardium with a strain g~e arch, and no effect 
was seen. However, the dose level used (2 mgm/Kgm) is far 
below the therapeutic dose. 
The few reports in the literature on the inotropic effects 
of procaine amide indicate that this drug is innocuous in this 
respect. High concentrations of the drug produce no de-
pression of contractility on turtle hearts (33) or isolated 
rabbit hearts (27). Since all other cardiovascular effects 
of procaine amide are similar to those of quinidine (14,22, 
27,33), it would be reasonable to expect that both drugs 
would have similar inotropic effects. 
It was decided to study the effects of these two drugs on 
cardiac contractility in the in the intact animal with the 
use of a strain guage arch sutured to the myocardium for the 
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following reasons: 
1. The inconclusive nature of the proof of the "well 
known" inotropic effects of the drugs. 
2. Direct measurement of changes in the force of 
ventricular contraction with a strain ~qge arch 
represents a sample of changes of force of the 
entire ventricular muscle under conditions of an 
intact circulation {9) . 
3. Measurement of contractile force is a more funda~ 
mental measurement of ventricular activity than is 
stroke work because the latter, although dependent 
on the former, is not directly related to the 
former under certain conditions (10), one of which 
bears directly on this problem, as discussed above. 
4. The obvious need to know what are the effects of 
these drugs on contractility because of the clini-
cal implications of such knowledge. 
Methods and Material 
Monerel dogs, weighing from ?.5-13.6 Kgm., selected at 
random, were anesthetized with intraperitoneal injections of 
pentobarbital sodium (33 mgm/Kgm). Blood pressures were 
obtained by use of a Hg manometer connected to the right 
~x.f-e-n.-tt.t-1 
carotid artery. ~he left jugular vein was cannulated for 
A 
purposes of drug infusions and injections. A left fourth 
intercostal thoracotomy was performed, the pericardial sac 
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opened, and a strain guage arch (4) sutured to the left 
ventricular wall. The sutures were placed deep enough (9) 
and with sufficient stretch applied to the underlying myo-
cardium to eliminate the possible effects of changes in heart 
size (9), and in order that there would be no variation in 
the percentage change of contractile force response to the 
drugs (8,31), even though the initial contractile forces 
might vary in different dogs (8). Contractile force and 
electrocardiograms (Lead II) were recorded simultaneously 
( f i ~ · \()) 
with a sanborn two channel recorder . A serie s of intravenous 
infusions were performed on dogs with open chests on positive 
respiration. These were done with a constant rate infusion 
l+ez.v ,~ 
pump. Total infus.ed doses were 34 to 58.5 mgm/Kgm quinidine ~ 
sulfate (equivalent to 28 - 48 .5 mgm/Kgm as quinidin e base) 
and 114 to 405 mgm/Kgm procaine amide. Infusion rates, 1/ ~~ • 
; 1.{£ __,_,w-r 
I .../ , 
. 'ilt.. ~~j constant for e ach dog were .5- 1.9 mgm/Kgm/min. quinidine 
bArr·Vf-;jJ-
sulfate ( .4- 1 . 6 mgm/Kgm/min . quinidine base) and 3.8- 11 .6 
mgm/Kgm/min . procaine amide . 
/IU.Arrcf--1' 
' 
· •"f-7. "-v I~ 
J .., - • 
physiolog ic saline in concentrations of 5 mgm/cc quinid~ne ~~ 
-~ . f.IJ ~ "' 0 fvvf ..,.;.~d . '-f; fJ h/£11 lb_i.t_ 
o'{4~; 
Slow intravenous injections were given to nonrespired Jf' >ff'U.._e......, -l.. 
The drugs were dissolved i n 
and 30 mgm/cc procaine amide . 
dogs with closed chests. Three dogs were done at each dose 
level of procaine amide, these being 10 3 25, 50, and 100 
mgm/Kgm. Four dogs were done at each dose level of quinidine 
gluc onate, 50 mgm/Kgm and 30 mgm/Kgm (31 .1 and 18.7 mgm/Kgm 
quinidine base) . Quinidine gluconate was used here for two 
reasons . First, it is more soluble than the sulfate, thus 
F~U-++~~ 
~\f\JV\_ J\f\f( \ J\J\Jl( J\J\J\_ 
Control 10 min. 20 min. 30 min. 
. - . -. - - ! 
~ - . 
"~~~~ 
I 
~ __f\__fiJ ~ ~ 
. ~111111. !IOmin. _ ; 60min. 70111in:. ·, 
- . 
·~~~~; 
, •.. IOOIIIin. llllmin. 1301111n. 
Figure lOo Typical simultaneous recordings of ECG (Lead II ) and 
systolic tension9 These are portions of the records 
for dog #2 in Table 1~ 
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allowing use of smaller volumes to give the desired dose, and 
second, it is known that the drug per se has no effect on the 
pH of blood (32). The concentration of drug used was 25 mgm/ 
cc. ~ecords, along with blood pressure readings, were taken 
at frequent intervals throughout all the experiments . 
Results 
Quinidine Sulfate Infusions 
~l{reliminary experiments to find a workable dose range~ 
~ show<~consistent depression of contractility, beginning 
to appear between doses equivalent to 6- 17 mgm/Kgm quinidine 
base. contractile force was cut to less than half the control 
values at doses which show other toxicities, e . g. severe hypo-
tension and complete depression of the S-A node . (see Table I). 
Mean blood pressures and changes in P- R, ~KS, and Q-T 
intervals, heart rate, and contractile force measured directly 
off the records were graphed against time (see Figure 1). 
The strain ~e arch was calibrated with known weights to 
insure that changes in tension on the arch and the recorded 
forces were linearly related (Figure 2). Contractile force 
(grams) was graphed as the ratio of dose effect/control 
value, thus allowing use of a common base line . 
quinidine Gluconate Injections 
Results here were similar to the preliminary infusion 
experiments . contractility was consistently depressed, the 
degree of depression being proportion~ to the dose given. 
Table 1. 
cardiovascular Effects of Infused Quinidine Gluconate ~Kf-
Time Dose ~~ean H. R. P-R Q.FS Q-T Contractile B. p . Force~: .. ·:~ .. :~ 
Hgm/ Bts/ Treated 
Min. Kgm Hm . Hg !i n . MSec. MSec. MSec . Gms . Control 
# 1 0 0 80 120 100 50 260 30 1.0 
15 6.~ 70 1 20 100 50 360 30 1.0 
30 12 . 60 100 110 60 380 30 1.0 
t~ 17.1 55 100 110 60 400 29 . 97 19.9 50 90 120 60 400 29 . 97 
55 23.5 45 80 120 70 410 22 • 73 
60 2~ . 9 45 80 120 70 420 20 .67 
70 2 .1~<- 40 80 130 70 430 20 .67 
90 45 80 130 70 430 20 . 67 
#2 0 0 90 120 90 40 230 27 1 . 0 
10 6.2 75 120 100 50 260 24 .90 
20 13.3 75 110 100 50 280 23 • 85 
30 20 .3 75 100 110 60 3[1 o 21 .77 
40 27 .. 4 75 80 110 60 3Bo ?0 • 74 
50 36.9 70 80 120 70 380 16 . 59 
60 48 .1~:- 60 60 130 80 390 13 . 4S 
70 60 60 140 80 400 15 . 55 
85 60 60 140 70 400 16 .59 
100 65 70 140 60 400 lS . 67 
115 65 75 140 60 LOO 20 • 74 
130 70 100 130 60 380 21 .77 
#3 0 0 85 170 80 50 230 38 1.0 
5 6.6 65 140 90 50 250 32 0 . 84 
10 16. 6 65 120 100 70 310 30 0 .79 
15 24 . 0 65 110 110 70 380 26 o . 6S 
20 33.2 55 100 120 80 400 24 .63 
25 42 .3 55 so 130 so 420 22 58 
30 48 . 5~:- 35 60 90 440 18 . 4 7 
40 35 60 90 450 1B 
·4 7 
47 40 60 110 80 450 18 
· 4 7 55 45 60 110 80 450 18 
-47 
65 55 80 110 70 450 21 . 55 
75 55 80 110 70 450 22 . 58 
90 55 60 110 70 450 25 . 66 
100 60 30 110 70 450 r,r' • (_ 6 c: :::' 
110 60 8c 110 70 450 ?5 . 66 
-:~ Infusion stopped . 
.. , .. 
,~-;,\" Total do se s are given as quinidine base . 
~H:~:- In these , and all other experiments, diastoli c tension was 
adjusted to approximate ly 50 grams . contrac tile force 
refers to systolic tension. 
QUINIDINE SULFATE INFUSION 
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Figure 2. calibration of the strain guage arch. Weights of 
10 grams were successively added to produce tension 
on the arch, up to a total of 210 gramse 
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Graphs were constructed as above (Figures 3 and 4). There is 
statistical significance at P = .05 between the means of the 
maximal responses ~Vthe dose levels used (~able II). 1 \} ~rjA 
, a\ ft1 d,. r~ I r' . I .. M /.K 
procaine Amide Infusions 
Effects on three do~s were variable and did not reveal 
a clear cut effective dose range, although dp:-__pression of 
contractility was seen. This approach was therefore abandoned, 
and injection experiments were done, choosing doses at above 
and below therapeutic dose levels. 
, I I procaine Amide Injections 
'}--tav' I~ .A/' ~ 
All dose levels used producedAdepression of myocardial 
contractility (Figures 5-8). The differ ences between the 
means of the maximal responseq/ (~able II) to 10 mgm/Kgm and 
25, 50, and 100 ~gm/Kgm, respectively, are statistically 
significant at p = .05. However, the differences between 
25, 50 and 100 mgm/Kgm are not significant, indicating that 
maximal depression is reached at approximately 25 mgm/Kgm, 
!J.,rl'<.f '4-).-!. 
and larger doses have little further effect on the degree of ~ ~'7l.l.-t.} 
depression. The duration of effect is, however, proportional ir ~-0A 
to the dose (Figures 5-8). 
Discussion 
It seems clear from the data presented above that both 
quinidine and procaine amide are capable of producing severe 
depression of myocardial contractility. The facts are in 
Table 2. 
Inotropic Effects of Quinidine and :Procaine Amide 
Contractile Force (Grams) Yean:. s .D. 
Drug Dose 
11gm/Kgm }1aximal Max. Eff . Max . Eff . Contro l Effect Control Control 
. 40 17 .42 
50 .39 21 . 54 .565±ell7 
.33 20 . 60 
Quinidine 50 35 . 70 
Glucona te-3:· 
25 16 ~64 
30 50 39 . 78 .78±.107 
31 25 • 80 
20 18 . 90 
39 17 · 44 
100 37 19 .51 .536±.112 
56 37 • 63 
29 18 .56 
50 40 24 . 60 .596i . 035 
Procaine 52 33 • 63 
Amide 
29 18 .62 
25 58 36 .62 . 623 . 005 
46 29 • 63 
38 32 • 84 
10 40 35 . 88 .. 866:!:. 023 
41 36 • 88 
~l- 50 -1- 30 mgm/Kgm are equivalent to 31 + 18.7 mgm/Kgm 
quinidine base . 
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agreement with previous notions about quinidine, but contrast 
sharply with the presently accepted idea that procaine amide 
has no effect on contractility. It is of interest that, on 
a weight basis, the degree of depression is essentially the 
same for both drue;s (Figure 9). Til ore significant, however, 
is the observation that at yherapeutic dose s the negative 
inotropic effect of procaine amide is much more severe than 
that of quinidine. These doses in dogs are a pproximately 
10- 15 mgm/Kgm quinidine gluconate (28) \ and 50 mgm/Kgm pro-
caine amide. Thus, it takes approximately three to five times 
the therapeutic dose of quinidine to produce the same degree 
of depression of contractility as the the rapeutic dose of 
procaine amide. This is significant in view of the fact that 
the therapeutic doses of thes~ drugs in man are related by 
/ ~~~A.~~· the mathematical ratio of 1:3 or 1:4, quinidine : procaine ~~-
,...,"J--r.~ . i7z 
amide (14,22), a ratio simular to that which exists in dogs. &·~ 
::l'_.d -01'~ 
ce.,. ~ 
The effects of these drugs on electrocardiograms, heart .. ~ ' 
t ~zz l. ~ 
· rate, and blood pressure are similar. P-R, QRS, a~q Q-\ ~ ~~ ~ ~ 
' 71! ~ !. ,::.. h-, ,. ~ ~ 
intervals are all prolonged . Since calculation of Q-Tc 'Or ~4 }:"' ' 
~c. ~'-· e t:.t.,.,.z~ ~ intervals showed the increase in Q- T intervals to be real, ~,~, 1 
--r ..... t: I I<;~ 
and not entirely dependent on changes in heart rate, the ~v~ ~ 
. lit/'~ ''t. 
Q-T ' s were graphed as measured from the records. Both drugs ~ ~1 1' produced a bradycardia and hypotension, but the latt~r effect 
f 11/1 1 ?~-1.1} , N • I · ... -1 .._,., • ,, / ~ 
, ' . -~t' ,. r/' is more mar ked after quinidine . study of Figures 3-8 will /"' 1 ~..tt~ 
show that the decrease in blood pressure 1)arallels the de-
crease in contractile force . The changes in contractility 
appear to lead those of blood pressure as both decrease, 
r ~U444··~~~Hfftt~mm~~~~ + 
' ' ~n 1--+-f-+t-+++ +++i+++l-t+++!+H+l++-++++-1-+tt!ftt+ttt+t+tt+ttttttt - 1-4-l--H-+-1-H+++-!+!-i+H- +-IH-t+++++t++t++++++i+t1111ftltt!,t _ ~ r --+--< I! t +++1-H-t-+H+H-H-fl'kltt-fttl a---+---<--+--1--+-1- ++-+++ 1+!+!-++H+H++++++++t+++ti#ttt+tttitlttt .. .. ' 
-h • 
'' 
-+- ......_-t 
T H+H++++t+-t+tt+t+tlttttt+ttlt-
Figure 9o Mean maximal reduction of contrac tile force ln 
response to intravenous doses of quinidine 
gluconate (X) and procaine amide (0). Points 
plotted in this greph are derived from data in 
Table 24 
~ 
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reach maximal effects, and then return to normal . In most 
experiments the contractile force returns to control values 
before blood pressure does . These facts rule out the possi -
bility that hypotensive ischemic effects on the myocardium 
might have contributed to depression of contractility . On 
the other hand , part of the hypotensive effects of the drugs 
may be due to reduction of contractile force as well as to a 
decrease in peripheral resistance (13,14,15) . 
Although the basic mechanism of action of these drugs 
is not known, there are numerous reports in the literature 
indicating that they interfere with the metabolism of cellu-
lar acetylcholine and electrolytes. Drugs such as anesthetic 
agents (18) and nitroglycerine (24) which depress contrac -
tility produce a simultaneous net gain of potassium by the 
myocardial cells. ftutonomic pressor drugs (24) and digitalis 
(7,26,28,29) increase contractile force and produce a simul-
taneous net loss of cellular potassium. The effects of 
acetylcholine vary, producing either a net gain (24) or net 
loss (18,19,21) of cellular potassium, depending on the ratio 
of intracellular to extracellular potassium (20), increasing 
efflux with low extracellular potassium and increasing in-
flux with low intracellular potassium. Pssociated with these 
changes are a decrease in contractile force (19,24) and 
arrythmias (21). 
~ 
7 
Quinidine (2,7,12 ,17,21) and procaine amide (1,28) effect 
potassium meta bolism simila~o other depressant drugs, pro-
ducing a net increase in cellular potassium . It has also been 
- 9 -
reported that quinidine (26) and procaine aMide (28) block 
the effects of digitalis on contractility and electrolytes. 
Quinidine and acetylcholine are mutually antagonistic with 
regard to potassimn flux (17,21), as are acetylcholine and 
anesthetic agents (18)) a significant fact when it is 
remembered that atropine also antagonizes acetylcholine (18, 
19). In addition, rapid acting anticholinesterases have 
electrical and mechanical effects indistinguishable from 
those of acetylcholine (23) and are inhibited by atropine. 
It has been suggested that maximal transfer of ions across 
the myocardial membrane occurs at conditions for op t imal 
cholinesterase activity (20) . Quinidine markedly inhibits 
cholinesterase activity (25). 
These studies indirectly indicate that quinidine may act 
by blocking intracellularly released acetylcholine (17), or 
by interfering with cholinesterase activity either directly 
(18,20,25) or secondarily due to direct effects on membrane 
permeability to ions (19 , 24) . The few reports on procaine 
amide indicating interference with ionic equilibrium (28) and 
cholinesterase activity (25) imply that this drug could have 
a similar mechanism of action. 
Since the effect of both these drugs seems to be inti -
mately concerned with acetylcholine, there is the possibili ty 
that some of these effects are due to autonomic reflexes . 
However, quinidine's depressant action onrtwthmicity and 
conduction appears to be directly on the myocardium with 
little or no effect being mediated through the autonomi c 
- 10 -
nervous system (32). The predominant effect of reflexly 
augmented sympathetic activity is on vasomotor tone Hith 
little effect on contractile force (11). Nevertheless, 
further experiments are indicated to rule out reflex activity 
on myocardial contractility. 
very recent work with quinidine (2,32) and procaine 
amide (1) indicate that their toxicity may be due to meta-
bolic acidosis. Evidence of electrocardiographic toxicity 
and hypotensive effects of both these drugs are correlated 
with a decrease in serum 002 and pH (2,32). This is a meta-
bolic response and not due to acidity of the drugs as such, 
as proved by in vitro studies (32). Molar sodium lactate 
reverses. the EGG toxicities, restores blood pressure to 
normotensive levels and simultaneously reverses the serum pH 
and 002 content to control values (1,2,32). It also decreases 
the serum potassium concentration, an effect which is known 
to improve rrwthmicity and conduction in myocardial cells (16). 
( Lowering extracellular potassium is also known to block the 
\ negative inotropic effect of quinidine on isolated rabbit 
\ atria (17). Plthough it is not known whether the primary 
mechanism involved in the changes above is alteration of 
electrolytes with subsequent pH changes or vice versa, the 
.. ,.,. 
u--•• 
s: 
;:-.... 
(' 
~ 
/ >~ 
~ ..! 
~ 
significant observation was made that molar sodiUM lactate ~ 
may be useful in treating clinically observed quinidine and 
procaine amide toxicities (1,2,32). It would be of interest 
~ 
to determine whether or not sodium lactate would also prevent '-'' 
..... 
~ 
.... 
t,. 
or reverse the inotropic effects of these drugs seen in our ,-" !' 
'\ 
experiments. ~. <:: 
" :.\ 
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summary 
Experiments on anesthetized dogs measuring contractile 
for c e directly from the myocardium with a strain g~e arch 
were performed to determine the inotropic effects of quini-
dine and procaine amide . 
Intravenous injections of quinidine gluconate and pro -
caine amide consistently depressed contractility, the degree 
of depression being directly correlated with increa sing doses 
of both drugs . 
on a weight-for-weight basis , the inotropic effects of 
. u;-C-f'"L,. 
these drugs ~er- essentially similar, but at therapeutic doses 
procaine amide }S,v~bre depressant than quinidine . / 
, , "-:1v( ,,,.,~~ 
possible mechanisms of action of these drugs wer~ dis -
{\ 
cussed , with refer ence to previous literature on the subject . 
- 12 -
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